Alibaba Health Information Technology Ltd Financials

Market Capitalization HK$89.64 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	38.85
Forward PE	24.86
Price to Sales TTM	HK$2.47
Price to Book MRQ	HK$4.17
Enterprise to Revenue	2.18
Enterprise to EBITDA	39.33

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2025-03-31
Most Recent Quarter	2025-09-30
Profit Margin	5.85%
Operating Margin	6.69%
Return on Assets TTM	5.16%
Return on Equity TTM	11.76%

Income Statement

Revenue TTM	HK$36,778,535,576
Revenue per Share TTM	HK$2.05
Quarterly Revenue Growth	17.00%
Gross Profit TTM	HK$9,001,827,726
EBITDA	HK$2,261,192,560
Net Income to Common TTM	HK$2,149,690,862
Diluted EPS TTM	HK$0.13
Quarterly Earnings Growth YoY	64.70%

Balance Sheet

Total Cash MRQ	HK$10,455,900,829
Total Cash per Share MRQ	HK$0.58
Total Debt MRQ	HK$
Total Debt to Equity MRQ	0.43
Current Ratio MRQ	2.71
Book Value per Share MRQ	HK$1.21

Cash Flow

Operating Cash Flow TTM	HK$1,555,210,547
Levered Free Cash Flow TTM	HK$636,434,195

0241 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	16,124,671,990
Float Shares	5,872,486,807
Avg 10 Volume	64,097,892
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	63.53%
% Held by Institutions	13.76%

Stock Price Summary

Beta	1.68
Fifty Two Week Low	HK$3.09
Fifty Two Week High	HK$7.50
Fifty Two Week Change	38.77%
Day 50 MA	HK$5.57
Day 200 MA	HK$5.30

Dividends and Splits

Forward Annual Dividend Rate	HK$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	HK$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date